The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer | MicrobiomeTrials← Back to trialsNCT04167969
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2021-02-17Est. Completion: 2027-11
Enrollment target: 16 participants Locations- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- Weill Cornell Medicine, New York, New York, United States
Other microbiome trials you might be interested in
Prostate Cancer
The purpose of this study is to evaluate the efficacy, and safety of HRS-5041 tablets combined with antitumor therapy in…
Harbin, ChinaEst. completion Jun 2026
Localised Prostate Cancer
The goal of this randomised clinical trial is to assess whether personalised treatment counselling can improve the decis…
Multiple LocationsEst. completion Nov 2027
Recruiting
Metastatic Breast CancerMetastatic Prostate CancerGRPR-Targeted Molecular ImagingTheranostic RadiopharmaceuticalsCancerActive CancerTheranosticRadiopharmaceutical
This is an open-label, first-in-human, exploratory Phase 0 study evaluating the safety and diagnostic imaging performanc…
Perth, AustraliaEst. completion May 30, 2028